Showing 11-20 of 23 grants

Title Institution Researcher Program Duration Total Award Amount
Autoimmune stem-like T cells in type 1 diabetes Memorial Sloan-Kettering Cancer Center Andrea Schietinger Cures 01-September-2023 to 31-August-2026 $750,000.00
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies Milliman Rebecca Smith Cures 01-January-2025 to 31-October-2025 $380,000.00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps Milliman Rebecca Smith Transportfolio 01-January-2025 to 01-October-2025 $545,000.00
GPR75, a novel actor in beta cell regeneration New York Medical College Ercument Dirice Cures 01-April-2022 to 31-March-2026 $750,000.00
Engineering hypoimmune cells for Type 1 Diabetes New York Stem Cell Foundation, Inc. Frederick J Monsma Jr Cures 01-May-2025 to 30-April-2028 $1,498,415.83
Triple therapy for T1DM with insulin, semaglutide and dapagliflozin The Research Foundation of SUNY on behalf of University at Buffalo Paresh Dandona Improving Lives 01-January-2019 to 31-March-2026 $1,808,522.70
Project Equity The Sonia Nabeta Foundation Vivian Nabeta Mission 01-May-2024 to 30-April-2026 $245,172.00
Achieving persistent presentation of self-antigens to reestablish tolerance and prevent autoimmune diabetes Trustees of Columbia University in the City of New York Camillo Bechi Genzano Cures 01-March-2025 to 29-February-2028 $256,285.00
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 31-May-2026 $599,999.94
In vivo analysis of human islet graft infiltration and its immunomodulation by antigen-specific therapy Trustees of Columbia University in the City of New York Remi Creusot Cures 01-August-2022 to 31-July-2025 $699,997.82